{"schema_version":"secwatch.filing_event.v1","accession":"0001517022-24-000035","form_type":"8-K","ticker":"AKBA","cik":"0001517022","company_name":"Akebia Therapeutics, Inc.","filed_at":"2024-04-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.777609+00:00","generated_at":"2026-06-03T11:51:30.553341+00:00","sec_items":["2.03"],"event_type":"debt","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Akebia draws $8.0M Tranche B from Kreos loan facility; $10.0M Tranche C still available","bullets":["Akebia drew $8.0M Tranche B loan on April 17, 2024, netting $7.5M after debt issuance costs and fees.","Remaining borrowing capacity under Tranche C is $10.0M, available through December 31, 2024.","Total facility remains $55M; initial $37M tranche was funded on January 29, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001517022-24-000035","json":"https://secwatch.observer/filing/0001517022-24-000035.json","markdown":"https://secwatch.observer/filing/0001517022-24-000035.md","text":"https://secwatch.observer/filing/0001517022-24-000035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1517022/000151702224000035/0001517022-24-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1517022/000151702224000035/akba-20242304xkreosdrawdown.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T11:51:30.553341+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"04bf1c7b236fb741b18251f6cc58d1d5f6ce4130","claim":"Akebia Therapeutics, Inc. incurred term loan of $8.0 million with Kreos Capital VII (UK) Limited, which are funds and accounts managed by BlackRock Inc..","evidence_excerpt":"tranche of $37.0 million, which was funded on the Closing Date. In addition to the initial tranche, the Term Loan Facility included additional tranches available as follows: $8.0 million available in a single draw through December 31, 2024 (the “Tranche B Loan”), and $10.0 million available in a single draw through December 31, 2024 (the “Tranche C Loan”). On","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1517022/000151702224000035/0001517022-24-000035-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"term loan"},{"label":"Principal","value":"$8.0 million"},{"label":"Counterparty","value":"Kreos Capital VII (UK) Limited, which are funds and accounts managed by BlackRock Inc."},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}